Align Technology | ALGN - Selling And Administration Expenses


Align Technology reported $410.55M in Selling and Administration Expenses for its fiscal quarter ending in September of 2026.





Selling And Administration Expenses Change Date
3M USD 921M 140M Sep/2026
Align Technology USD 410.55M 52.12M Sep/2026
Becton, Dickinson and Co. USD 1.26B 1000K Sep/2026
Bruker USD 226.5M 12.4M Sep/2026
Cardinal Health USD 1.6B 30M Sep/2026
Charles River Laboratories USD 140.59M 88.31M Sep/2026
Cooper Companies USD 401.3M 274.9M Jun/2026
Danaher USD 2.16B 87M Sep/2026
Dentsply International USD 363M 1000K Sep/2026
Dexcom USD 358.7M 9M Jun/2026
Henry Schein USD 819M 12M Sep/2026
Idexx Laboratories USD 293.13M 5.04M Sep/2026
Insulet USD 350.7M 5.9M Sep/2026
Integra LifeSciences USD 161.02M 5.2M Sep/2026
IQVIA Holdings USD 569M 5M Sep/2026
McKesson USD 2.27B 5M Sep/2026
Mettler Toledo International USD 267.16M 3.82M Sep/2026
Revvity USD 275.33M 3.25M Sep/2026
Solventum Corp USD 813M 114M Sep/2026
Stryker USD 2.12B 32M Jun/2026
Teleflex USD 220.72M 7.21M Sep/2026
Thermo Fisher Scientific USD 1.86B 46M Sep/2026
Veeva Systems USD 138.88M 12.4M Jun/2026
Waters USD 398M 7M Sep/2026
Zimmer Biomet Holdings USD 855M 56.6M Sep/2026
Zoetis USD 582M 10M Sep/2026